Skip to main content

Table 1 Characteristics of patients included in analysis (n = 69)

From: Ability of the Analgesia Nociception Index variations to identify a response to a volume expansion of 250 mL of crystalloids in the operating room (REVANI): a prospective observational study

Characteristics

 

Age, yr

57 (14)

Sex, Female, n (%)

35 (51)

ASA physical status (%)

 1

1 (2)

 2

21 (30)

 3

47 (68)

BMI, kg.m −2

26 (5)

Body weight, kg

72 (16)

Ideal body weight, kg

62 (7)

Comorbidities

 Chronic hypertension

11 (16)

 Diabetes

1 (1)

 Tabacco

21 (30)

 Alcohol consumption

5 (7)

 Stable cardiovascular disease

3 (4)

 Stable pulmonary disease

13 (19)

Treatment, n (%)

 Antihypertensive

11 (16)

 Including CEI/ARBs

10 (15)

Position, n (%)

 Supine position

46 (67)

 Partial lateral decubitus

23 (33)

Surgery, n (%)

 Brain tumor

58 (84)

 Aneurysm

6 (9)

 Others

5 (7)

Length of surgery, h

3 (1)

Tidal volume of ideal body weight (ml.kg −1 )

7.2 (0.7)

Ventilatory frequency (cycles.min −1 )

14 [12 – 1]

PEEP (cmH 2 0)

6 [5, 6]

Number of patients receiving

 1 fluid challenge, n

41

 2 fluid challenges, n

19

 3 fluid challenges, n

6

 4 fluid challenges, n

3

  1. Values are mean (standard deviation), median [25–75% interquartile range] or number (%) as appropriate
  2. ACEi Angiotension Conversion Enzyme inhibitor, ARBs Angiotensin Receptor Blockers
  3. T0: baseline
  4. T1: 4–5 min after the end of volume expansion